Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian B Filion

Showing results (21-30 of 303) with videos related to

Pageof 31
Sort By:
BMC Cardiovascular Disorders|June 22, 2011
Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trialsPeter Bogaty, Kristian B Filion, James M Brophy
JAMA Neurology|July 6, 2016
Stent Retrievers for Treating Anterior Circulation Acute Ischemic Stroke-ReplyLahoud Touma, Kristian B Filion, Mark J Eisenberg
Archives of Internal Medicine|July 15, 2009
Improving the clinician-scientist pathway: a survey of clinician-scientistsElie Donath, Kristian B Filion, Mark J Eisenberg
The American Journal of Medicine|February 16, 2013
The replySayuri Friedland, Kristian B Filion, Mark J Eisenberg
American Heart Journal|February 16, 2010
Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysisDominique Joyal, Kristian B Filion, Mark J Eisenberg
Journal of Cardiac Failure|July 31, 2010
Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agentsPatrick R Lawler, Kristian B Filion, Mark J Eisenberg
JAMA|July 2, 2009
Adverse outcomes associated with use of proton pump inhibitors and clopidogrelVerena Schneider-Lindner, Kristian B Filion, James M Brophy
American Heart Journal|October 11, 2011
Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trialsPatrick R Lawler, Kristian B Filion, Mark J Eisenberg
JAMA|March 9, 2021
Use of e-Cigarettes for Smoking Cessation-ReplyMark J Eisenberg, Andréa Hébert-Losier, Kristian B Filion
Trends in Cardiovascular Medicine|March 15, 2017
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitorsMatthew H Secrest, Jacob A Udell, Kristian B Filion
Pageof 31

Showing results (21-30 of 303) with videos related to

Sort By:
Pageof 31
BMC Cardiovascular Disorders|June 22, 2011
Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trialsPeter Bogaty, Kristian B Filion, James M Brophy
JAMA Neurology|July 6, 2016
Stent Retrievers for Treating Anterior Circulation Acute Ischemic Stroke-ReplyLahoud Touma, Kristian B Filion, Mark J Eisenberg
Archives of Internal Medicine|July 15, 2009
Improving the clinician-scientist pathway: a survey of clinician-scientistsElie Donath, Kristian B Filion, Mark J Eisenberg
The American Journal of Medicine|February 16, 2013
The replySayuri Friedland, Kristian B Filion, Mark J Eisenberg
American Heart Journal|February 16, 2010
Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysisDominique Joyal, Kristian B Filion, Mark J Eisenberg
Journal of Cardiac Failure|July 31, 2010
Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agentsPatrick R Lawler, Kristian B Filion, Mark J Eisenberg
JAMA|July 2, 2009
Adverse outcomes associated with use of proton pump inhibitors and clopidogrelVerena Schneider-Lindner, Kristian B Filion, James M Brophy
American Heart Journal|October 11, 2011
Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trialsPatrick R Lawler, Kristian B Filion, Mark J Eisenberg
JAMA|March 9, 2021
Use of e-Cigarettes for Smoking Cessation-ReplyMark J Eisenberg, Andréa Hébert-Losier, Kristian B Filion
Trends in Cardiovascular Medicine|March 15, 2017
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitorsMatthew H Secrest, Jacob A Udell, Kristian B Filion
Pageof 31